|
1
|
Wynn TA: Common and unique mechanisms
regulate fibrosis in various fibroproliferative diseases. J Clin
Invest. 117:524–529. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo Y, Li Z, Ding R, Li H, Zhang L, Yuan W
and Wang Y: Parathyroid hormone induces epithelial-to-mesenchymal
transition via the Wnt/β-catenin signaling pathway in human renal
proximal tubular cells. Int J Clin Exp Pathol. 7:5978–5987.
2014.PubMed/NCBI
|
|
3
|
Lan HY: Diverse roles of TGF-β/Smads in
renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Becker LE, Weritz B, Yi X, Gross-Weissmann
ML, Waldherr R, Zeier M and Sommerer C: Evolution of allograft
fibrosis and function in kidney transplant recipients: A
retrospective analysis of stable patients under CNI and mTORi.
Transpl Int. 28:553–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li TT, Zhang XH, Jing JF, Li X, Yang XQ,
Zhu FH, Tang W and Zuo JP: Artemisinin analogue SM934 ameliorates
the proteinuria and renal fibrosis in rat experimental membranous
nephropathy. Acta Pharmacol Sin. 36:188–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lan HY: Tubular epithelial-myofibroblast
transdifferentiation mechanisms in proximal tubule cells. Curr Opin
Nephrol Hypertens. 12:25–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakao A, Imamura T, Souchelnytskyi S,
Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH,
Miyazono K and ten Dijke P: TGF-beta receptor-mediated signalling
through Smad2, Smad3 and Smad4. EMBO J. 16:5353–5362. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao Y, Mao X, Sun C, Zheng P, Gao J, Wang
X, Min D, Sun H, Xie N and Cai J: Baicalin attenuates global
cerebral ischemia/reperfusion injury in gerbils via anti-oxidative
and anti-apoptotic pathways. Brain Res Bull. 85:396–402. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang YJ, Zhou FW, Luo ZQ, Li XZ, Yan HM,
Wang MJ, Huang FR and Yue SJ: Multiple therapeutic effects of
adjunctive baicalin therapy in experimental bacterial meningitis.
Inflammation. 33:180–188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu J, Wang J, Sheng Y, Zou Y, Bo L, Wang
F, Lou J, Fan X, Bao R, Wu Y, et al: Baicalin improves survival in
a murine model of polymicrobial sepsis via suppressing inflammatory
response and lymphocyte apoptosis. PLoS One. 7:e355232012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin M, Li L, Li L, Pokhrel G, Qi G, Rong R
and Zhu T: The protective effect of baicalin against renal
ischemia-reperfusion injury through inhibition of inflammation and
apoptosis. BMC Complement Altern Med. 14:192014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng XD, Dai LL, Huang CQ, He CM and Chen
LJ: Correlation between anti-fibrotic effect of baicalin and serum
cytokines in rat hepatic fibrosis. World J Gastroenterol.
15:4720–4725. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu Q, Noor M, Wong YF, Hylands PJ,
Simmonds MS and Xu Q, Jiang D, Hendry BM and Xu Q: In vitro
anti-fibrotic activities of herbal compounds and herbs. Nephrol
Dial Transplant. 24:3033–3041. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Satoh M, Kashihara N, Yamasaki Y, Maruyama
K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K and
Makino H: Renal interstitial fibrosis is reduced in angiotensin II
type 1a receptor-deficient mice. J Am Soc Nephrol. 12:317–325.
2001.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang DT, Huang RH, Cheng X, Zhang ZH, Yang
YJ and Lin X: Tanshinone IIA attenuates renal fibrosis and
inflammation via altering expression of TGF-β/Smad and NF-κB
signaling pathway in 5/6 nephrectomized rats. Int Immunopharmacol.
26:4–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li L, Chen L, Zang J, Tang X, Liu Y, Zhang
J, Bai L, Yin Q, Lu Y, Cheng J, et al: C3a and C5a receptor
antagonists ameliorate endothelial-myofibroblast transition via the
Wnt/β-catenin signaling pathway in diabetic kidney disease.
Metabolism. 64:597–610. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Denby L, Ramdas V, Lu R, Conway BR, Grant
JS, Dickinson B, Aurora AB, McClure JD, Kipgen D, Delles C, et al:
MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc
Nephrol. 25:65–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jia H, Chen XL, Chen C, Hu YY and Yun XJ:
Baicalin prevents the up-regulation of connective tissue growth
factor in fibrotic lungs of rats. Sheng Li Xue Bao. 62:535–540.
2010.(In Chinese). PubMed/NCBI
|
|
20
|
Liu P, Yan S, Chen M, Chen A, Yao D, Xu X,
Cai X, Wang L and Huang X: Effects of baicalin on collagen I and
collagen III expression in pulmonary arteries of rats with hypoxic
pulmonary hypertension. Int J Mol Med. 35:901–908. 2015.PubMed/NCBI
|
|
21
|
Qiao H, Tong Y, Han H, Xu W, Ren Z, Ouyang
J and Chen Y: A novel therapeutic regimen for hepatic fibrosis
using the combination of mesenchymal stem cells and baicalin.
Pharmazie. 66:37–43. 2011.PubMed/NCBI
|
|
22
|
Yang MD, Chiang YM, Higashiyama R, Asahina
K, Mann DA, Mann J, Wang CC and Tsukamoto H: Rosmarinic acid and
baicalin epigenetically derepress peroxisomal
proliferator-activated receptor γ in hepatic stellate cells for
their antifibrotic effect. Hepatology. 55:1271–1281. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang W, Zhou PH, Xu CG, Zhou XJ, Hu W and
Zhang J: Baicalein attenuates renal fibrosis by inhibiting
inflammation via down-regulating NF-κB and MAPK signal pathways. J
Mol Histol. 46:283–290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Masszi A and Kapus A: Smaddening
complexity: The role of Smad3 in epithelial-myofibroblast
transition. Cells Tissues Organs. 193:41–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O'Connor JW and Gomez EW: Cell adhesion
and shape regulate TGF-beta1-induced epithelial-myofibroblast
transition via MRTF-A signaling. PLoS One. 8:e831882013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zeisberg M and Kalluri R: The role of
epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med
(Berl). 82:175–181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang J, Shultz RW, Mars WM, Wegner RE, Li
Y, Dai C, Nejak K and Liu Y: Disruption of tissue-type plasminogen
activator gene in mice reduces renal interstitial fibrosis in
obstructive nephropathy. J Clin Invest. 110:1525–1538. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lebrin F, Deckers M, Bertolino P and Ten
DP: TGF-beta receptor function in the endothelium. Cardiovasc Res.
65:599–608. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ding Y and Choi ME: Regulation of
autophagy by TGF-β: Emerging role in kidney fibrosis. Semin
Nephrol. 34:62–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
